Publication | Closed Access
Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma
24
Citations
15
References
2018
Year
Our data showed that, cabozantinib is a active and feasible treatment in patient with nonclear cell RCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1